Biomarkers and Therapeutic Targets: microRNA Roles in the Pathophysiology, Diagnosis and Management of Eosinophilic Esophagitis

Kristin A. Lambert, Punit Jhaveri, Pooja Jhaveri

Research output: Contribution to journalArticle

Abstract

Eosinophilic esophagitis (EoE) is a chronic inflammatory disease that is increasingly recognized as the cause of common gastrointestinal symptoms including dysphagia, chest and abdominal pain, heartburn, food impaction, and food refusal in children and adults. Often referred to as “asthma of the esophagus”, eosinophilic esophagitis, like its asthma counterpart, is an allergic disorder on the rise worldwide. Clinically managed by food avoidance, steroid therapy, recurring endoscopic evaluations and dilations as needed, eosinophilic esophagitis is a poorly understood disease process with limited therapies and even fewer diagnostic tools to predict and surveil active inflammation. As a result, there is a critical need to identify noninvasive biomarkers and therapeutic targets for eosinophilic esophagitis. Here we review the known contributions of miRNAs to eosinophilic inflammation of the esophagus and the potential for miRNA biomarkers for EoE in the clinical setting.
Original languageEnglish (US)
JournalJournal of Translational Genetics and Genomics
Volume2
Issue number11
StatePublished - Aug 8 2018

Fingerprint Dive into the research topics of 'Biomarkers and Therapeutic Targets: microRNA Roles in the Pathophysiology, Diagnosis and Management of Eosinophilic Esophagitis'. Together they form a unique fingerprint.

  • Cite this